https://www.thepeptidenewsroom.com/usa-today-shopping-feature-spotlights-multi-collagen-powder-but-cites-no-clinica/ The Peptide Newsroom en 2026-08-27 USA TODAY Shopping Feature Spotlights Multi Collagen Powder, But Cites No Clinical Studies https://www.thepeptidenewsroom.com/nad-skincare-trend-draws-buzz-but-shopping-feature-cites-no-published-trials/ The Peptide Newsroom en 2026-08-27 NAD+ Skincare Goes Mainstream, But the Evidence Behind It Is a Shopping Page https://www.thepeptidenewsroom.com/logistics-firm-says-fda-panel-vote-will-lift-peptide-demand-but-names-no-peptide/ The Peptide Newsroom en 2026-08-27 Logistics Firm Says FDA Panel Vote Will Lift Peptide Demand, But Names No Peptides https://www.thepeptidenewsroom.com/glp-1-drugs-linked-to-lower-pseudarthrosis-odds-after-neck-fusion-but-other-outc/ The Peptide Newsroom en 2026-08-27 GLP-1 Drugs Linked to Lower Pseudarthrosis Odds After Neck Fusion, But Other Outcomes Unclear https://www.thepeptidenewsroom.com/glp-1-drugs-linked-to-lower-hospitalization-and-death-rates-in-dialysis-patients/ The Peptide Newsroom en 2026-08-27 GLP-1 Use Linked to Lower Hospitalization and Death in Dialysis Patients, But the Design Is Retrospective https://www.thepeptidenewsroom.com/faers-analysis-reports-gastric-emptying-signal-for-five-glp-1-drugs-but-authors-/ The Peptide Newsroom en 2026-08-27 FAERS Analysis Flags Gastric Emptying Signal for Five GLP-1 Drugs, But Authors Say It Is Not Risk https://www.thepeptidenewsroom.com/exercise-mimicking-pill-env-308-clears-first-human-trial-but-doctors-say-weight-/ The Peptide Newsroom en 2026-08-27 Exercise-Mimicking Pill ENV-308 Clears First Human Trial, But the Weight Data Does Not Exist Yet https://www.thepeptidenewsroom.com/dermatologists-tell-vogue-collagen-peptides-may-help-skin-modestly-but-not-repla/ The Peptide Newsroom en 2026-08-27 Vogue's Dermatologists Warm to Collagen Peptides, But Call the Skin Effects Modest https://www.thepeptidenewsroom.com/all-nine-glp-1-products-show-gastric-emptying-reporting-signal-but-authors-say-c/ The Peptide Newsroom en 2026-08-27 All Nine GLP-1 Products Hit a Gastric Emptying Reporting Signal, But Authors Say Causation Is Unproven https://www.thepeptidenewsroom.com/experts-say-synthetic-peptides-are-popular-for-recovery-and-sleep-but-evidence-i/ The Peptide Newsroom en 2026-08-26 Experts Say Synthetic Peptides Are Booming for Recovery and Sleep, But the Evidence Is Thin https://www.thepeptidenewsroom.com/experts-link-glp-1-weight-loss-to-bone-density-loss-but-say-habits-change-the-ou/ The Peptide Newsroom en 2026-08-26 Experts Link GLP-1 Weight Loss to Bone Density Loss, But Say the Pace Matters More https://www.thepeptidenewsroom.com/dulaglutide-reduced-liver-injury-markers-in-diabetic-mice-with-fatty-liver-disea/ The Peptide Newsroom en 2026-08-26 Dulaglutide Cut Liver Injury Markers in Diabetic Mice, But the Study Stops at the Mouse https://www.thepeptidenewsroom.com/charleston-providers-say-peptide-excitement-is-outpacing-science-but-approved-gl/ The Peptide Newsroom en 2026-08-26 Charleston Providers Say Peptide Excitement Is Outpacing Science, But Approved GLP-1s Remain Well Studied